Physician profile
Michael Duong
NPI 1720258361
$2,318.12
in general payments reported to CMS, 2019-2025
12 companies · $763 in 2025
The $763 reported for 2025 was more than what 86% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $105 · 2021: $258 · 2022: $338 · 2023: $333 · 2024: $111 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.33 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,098.30 | 2019-2025 | Invisalign, Touch Up, Invisalign Touch Up |
| Straumann USA LLC | $400.00 | 2025 | |
| Ormco Corporation | $210.13 | 2021-2023 | Damon |
| Purelife, LLC | $190.00 | 2019-2020 | |
| Gc America INC. | $155.38 | 2019 | |
| Envista Holdings Corporation | $68.61 | 2024-2025 | Damon, Insignia |
| Dentsply Sirona INC | $49.21 | 2019 | |
| Carestream Dental, LLC | $41.25 | 2019 | |
| Biohorizons Implant Systems INC. | $35.00 | 2023 | Biohorizons |
| Nobel Biocare USA | $32.78 | 2023 | Nobelactive |
| Ortho Organizers, INC. | $19.83 | 2020 | |
| Patterson Companies, INC. | $17.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.